CVE-2026-134382: frappe erpnext · Incorrect Authorization
Affects frappe erpnextSource CVE Database V5
Not known to be exploited · CVSS 5.3 Medium : upgrade to 15.121.4 when convenient.
Data as of 21 Nov 2026, 17:13 UTC
Thin evidence
One scorer or none| CNA (VulnCheck) | CVSS 4.0 | 5.3 |
|---|---|---|
| CNA (VulnCheck) | CVSS 3.1 | 4.3 |
- Patch
- Available – fixed in 15.121.4, 16.36.0
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:N/VI:L/VA:N/SC:N/SI:N/SA:NExploitation evidence
Disclosed: evidence found.
CVE published 21 Nov 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponized: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 20 Nov 2026.
What to do
Upgrade erpnext to 15.121.4; erpnext to 16.36.0.
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| frappeerpnext | Affected
| Fixed in
|
| frappeerpnext | Affected
| Fixed in
|
AI-suggested
This vulnerability is fixed in Frappe ERPNext versions 15.121.4 and 16.36.0. Users should upgrade to these or later versions to remediate the issue. No additional mitigation steps are indicated by the vendor advisory.
Description
CVE-2026-134382 is an authorization vulnerability in Frappe ERPNext affecting versions 5.0.0 before 15.121.4 and 16.x before 16.36.0. The flaw exists in a Selling module endpoint that improperly checks only document-type write permission rather than verifying permissions on individual Sales Orders. This allows authenticated users with restricted User Permissions to craft requests to close or reopen Sales Orders belonging to other companies, bypassing intended access controls.